PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.

by Laszlo Deres, Eva Bartha, Anita Palfi, Krisztian Eros, Adam Riba, Janos Lantos, Tamas Kalai, Kalman Hideg, Balazs Sumegi, Ferenc Gallyas, Kalman Toth, Robert Halmosi
Published 2014-01-01